Rat study shows gut microbes play a role in colon cancer susceptibility

July 13, 2016

The microscopic organisms that live in our gut do more than help us digest food. A new study in rats bolsters a growing body of evidence that the complex mix of microorganisms found in the gut, known as gut microbiota, could influence a person's likelihood of developing colon cancer.

Previous studies in humans have shown that cancer is associated with changes in gut microbiota. In the new study, researchers from the University of Missouri in Columbia used rats to further explore the possible relationship between cancer and bacteria in the gut. They implanted embryos from a strain of rats genetically engineered to develop colon cancer into the wombs of three other strains of rats, each with distinct gut microbiota: F344/NHsd (F344), LEW/SsNHsd (LEW), and Crl:SD (SD).

By 1.5 months, the microbiota of the pups, which typically develop tumors by 2 to 4 months of age, resembled that of their surrogate mothers. The researchers looked for tumors when the pups had reached 6 months of age and found that rats with the LEW microbiota developed significantly fewer tumors than the other strains. In fact, two of the rats with the LEW strain gut microbiota did not develop colon tumors at all. The researchers also found more tumors in the rats with the F344 gut microbiota that had higher levels of Peptococcaceae and Akkermansia muciniphila bacteria in their guts. Overall, findings from this study provide new insight into the role of gut microbiota as a modulator and a predictor of cancer in this rat model.

Susheel Busi will present this research from 2:30-2:45 p.m. during the Cancer and Immunology Symposium in Crystal Ballroom G1 as part of The Allied Genetics Conference, Orlando World Center Marriott, Orlando, Florida.

Genetics Society of America

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.